Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Neomycin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Ruddy, J., Proops, D. W., Pearman, K., and Ruddy, H. Department of ENT Surgery, Birmingham Children's Hospital, U.K Management of epistaxis in children Int.J.Pediatr.Otorhinolaryngol. 1991;21:139-142.
    Active substance: CHLORHEXIDINE_AND_NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 23935
    Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.
    Active substance: CIPROFLOXACIN
    Study summary document link (including results):
    View full study record
    Document reference: 24248
    Study title: A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5.
    Active substance: CIPROFLOXACIN
    Study summary document link (including results):
    View full study record
    Document reference: 24235
    Study title: A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. Ear Drops and Otosporin Ear Drops in otitis externa. Bain DJ. J Int Med Res. 1976;4(1):79-81.A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. Ear Drops and Otosporin Ear Drops in otitis externa. Bain DJ. J Int Med Res. 1976;4(1):79-81.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24257
    Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24263
    Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24282
    Study title: Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. Poetker DM, Lindstrom DR, Patel NJ, Conley SF, Flanary VA, Link TR, Kerschner JE. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1294-8. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. Poetker DM, Lindstrom DR, Patel NJ, Conley SF, Flanary VA, Link TR, Kerschner JE. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1294-8.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24279
    Study title: Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH. Curr Med Res Opin. 2006 Sep;22(9):1725-36. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH. Curr Med Res Opin. 2006 Sep;22(9):1725-36.
    Active substance: CIPROFLOXACIN HYDROCORTIZONE
    Study summary document link (including results):
    View full study record
    Document reference: 24280
    Study title: Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language).Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language).
    Active substance: DEXAMETHASONE AND NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 25750
    Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5.
    Active substance: DEXAMETHASONE AND NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 25744
    Study title: Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8.
    Active substance: DEXAMETHASONE AND NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 25748
    Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.
    Active substance: DEXAMETHASONE AND NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 25747
    Study title:
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results): Neomycin sulfate-polymixin B-Dexmthasone - C-94-28.xls
    View full study record
    Document reference: 47627
    Study title: A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results): A prospective randomized study of medications.pdf
    View full study record
    Document reference: 25763
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25757
    Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25761
    Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25756
    Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25759
    Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25758
    Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92..
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25760
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Jul 04 20:30:41 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA